CA2106487A1 - Anticorps monoclonal pd41 et antigene associe aux adenocarcinomes de la prostate - Google Patents

Anticorps monoclonal pd41 et antigene associe aux adenocarcinomes de la prostate

Info

Publication number
CA2106487A1
CA2106487A1 CA002106487A CA2106487A CA2106487A1 CA 2106487 A1 CA2106487 A1 CA 2106487A1 CA 002106487 A CA002106487 A CA 002106487A CA 2106487 A CA2106487 A CA 2106487A CA 2106487 A1 CA2106487 A1 CA 2106487A1
Authority
CA
Canada
Prior art keywords
prostate
antigen
monoclonal antibody
mab
carcinoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002106487A
Other languages
English (en)
Inventor
George L. Wright, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastern Virginia Medical School
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002106487A priority Critical patent/CA2106487A1/fr
Priority to PCT/US1992/000852 priority patent/WO1993014775A1/fr
Priority claimed from PCT/US1992/000852 external-priority patent/WO1993014775A1/fr
Publication of CA2106487A1 publication Critical patent/CA2106487A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002106487A 1992-01-31 1992-01-31 Anticorps monoclonal pd41 et antigene associe aux adenocarcinomes de la prostate Abandoned CA2106487A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002106487A CA2106487A1 (fr) 1992-01-31 1992-01-31 Anticorps monoclonal pd41 et antigene associe aux adenocarcinomes de la prostate
PCT/US1992/000852 WO1993014775A1 (fr) 1992-01-31 1992-01-31 Anticorps monoclonal pd41 et antigene associes aux carcinomes de la prostate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002106487A CA2106487A1 (fr) 1992-01-31 1992-01-31 Anticorps monoclonal pd41 et antigene associe aux adenocarcinomes de la prostate
PCT/US1992/000852 WO1993014775A1 (fr) 1992-01-31 1992-01-31 Anticorps monoclonal pd41 et antigene associes aux carcinomes de la prostate

Publications (1)

Publication Number Publication Date
CA2106487A1 true CA2106487A1 (fr) 1993-08-01

Family

ID=4152334

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002106487A Abandoned CA2106487A1 (fr) 1992-01-31 1992-01-31 Anticorps monoclonal pd41 et antigene associe aux adenocarcinomes de la prostate

Country Status (1)

Country Link
CA (1) CA2106487A1 (fr)

Similar Documents

Publication Publication Date Title
US5227471A (en) Monoclonal antibody PD41 that binds to a prostate mucin antigen that is expressed in human prostatic carcinoma
EP0914155B1 (fr) Anticorps monoclonaux de l'antigene membranaire specifique de la prostate
US7201900B2 (en) Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
US5817313A (en) Monoclonal antibodies and conjugates thereof useful for the treatment of cancer
FI88808B (fi) Menetelmä monoklonaalisten vasta-aineiden valmistamiseksi ihmisen ei-pienisoluisia keuhkosyöpäkasvaimia varten
US5506343A (en) Antibodies specific for the DF3 carcinoma associated antigen
US7476513B2 (en) Monoclonal antibody specific for the extracellular domain of prostate specific membrane antigen
JP2589682B2 (ja) ヒト非▲下−▼小細胞肺癌に関するモノクローナル抗体および抗原
EP1854808A2 (fr) Anticorps monoclonaux spécifiques pour le domaine extracellulaire de l'antigène membranaire spécifique de la prostate
US5185432A (en) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas
FI85814C (fi) Foerfarande foer producering av en monoklonal antikropp foer humana icke-litencellslungcancer.
EP0352722A2 (fr) Procédés de liaison d'antigène d'adènocarcinome et réactifs
Beckett et al. Monoclonal antibody PD41 recognizes an antigen restricted to prostate adenocarcinomas
Burchell et al. Antibodies to human milk fat globule molecules
WO1994009811A1 (fr) Molecule d'adherence
EP0726914B1 (fr) Proteine de membranes cellulaires exprimee par les thymocites du cortex humain, et son emploi
US5077220A (en) Monoclonal antibody specific to a novel glycoprotein antigen on human carcinoma cells
EP0203552B1 (fr) Anticorps monoclonaux pour les carcinomes du poumon humain du type à cellules non petites
US5863540A (en) Adhesion molecule
CA2106487A1 (fr) Anticorps monoclonal pd41 et antigene associe aux adenocarcinomes de la prostate
WO1993014775A1 (fr) Anticorps monoclonal pd41 et antigene associes aux carcinomes de la prostate
Price Breast-cancer-associated antigens defined by monoclonal antibodies
JPS63222700A (ja) モノクロ−ナル抗体

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 19991216